These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 17346964)

  • 1. Carbonic anhydrase inhibitors: the X-ray crystal structure of the adduct of N-hydroxysulfamide with isozyme II explains why this new zinc binding function is effective in the design of potent inhibitors.
    Temperini C; Winum JY; Montero JL; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2007 May; 17(10):2795-801. PubMed ID: 17346964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with a topically acting antiglaucoma sulfonamide.
    Abbate F; Casini A; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2004 May; 14(9):2357-61. PubMed ID: 15081040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbonic anhydrase inhibitors. X-ray crystal studies of the carbonic anhydrase II-trithiocarbonate adduct--an inhibitor mimicking the sulfonamide and urea binding to the enzyme.
    Temperini C; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2010 Jan; 20(2):474-8. PubMed ID: 20005709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II "selective" inhibitor celecoxib.
    Di Fiore A; Pedone C; D'Ambrosio K; Scozzafava A; De Simone G; Supuran CT
    Bioorg Med Chem Lett; 2006 Jan; 16(2):437-42. PubMed ID: 16290146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbonic anhydrase inhibitors. Zonisamide is an effective inhibitor of the cytosolic isozyme II and mitochondrial isozyme V: solution and X-ray crystallographic studies.
    De Simone G; Di Fiore A; Menchise V; Pedone C; Antel J; Casini A; Scozzafava A; Wurl M; Supuran CT
    Bioorg Med Chem Lett; 2005 May; 15(9):2315-20. PubMed ID: 15837316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbonic anhydrase inhibitors: X-ray crystallographic studies for the binding of 5-amino-1,3,4-thiadiazole-2-sulfonamide and 5-(4-amino-3-chloro-5-fluorophenylsulfonamido)-1,3,4-thiadiazole-2-sulfonamide to human isoform II.
    Menchise V; De Simone G; Di Fiore A; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2006 Dec; 16(24):6204-8. PubMed ID: 17000110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbonic anhydrase inhibitors. Interaction of 2-N,N-dimethylamino-1,3,4-thiadiazole-5-methanesulfonamide with 12 mammalian isoforms: kinetic and X-ray crystallographic studies.
    Temperini C; Cecchi A; Boyle NA; Scozzafava A; Cabeza JE; Wentworth P; Blackburn GM; Supuran CT
    Bioorg Med Chem Lett; 2008 Feb; 18(3):999-1005. PubMed ID: 18162396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbonic anhydrase inhibitors. Comparison of chlorthalidone, indapamide, trichloromethiazide, and furosemide X-ray crystal structures in adducts with isozyme II, when several water molecules make the difference.
    Temperini C; Cecchi A; Scozzafava A; Supuran CT
    Bioorg Med Chem; 2009 Feb; 17(3):1214-21. PubMed ID: 19119014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbonic anhydrase inhibitors. Interaction of 2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide with 12 mammalian isoforms: kinetic and X-ray crystallographic studies.
    Güzel O; Temperini C; Innocenti A; Scozzafava A; Salman A; Supuran CT
    Bioorg Med Chem Lett; 2008 Jan; 18(1):152-8. PubMed ID: 18024029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbonic anhydrase inhibitors: X-ray and molecular modeling study for the interaction of a fluorescent antitumor sulfonamide with isozyme II and IX.
    Alterio V; Vitale RM; Monti SM; Pedone C; Scozzafava A; Cecchi A; De Simone G; Supuran CT
    J Am Chem Soc; 2006 Jun; 128(25):8329-35. PubMed ID: 16787097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbonic anhydrase activators: X-ray crystal structure of the adduct of human isozyme II with L-histidine as a platform for the design of stronger activators.
    Temperini C; Scozzafava A; Puccetti L; Supuran CT
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5136-41. PubMed ID: 16214338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbonic anhydrase inhibitors: clash with Ala65 as a means for designing inhibitors with low affinity for the ubiquitous isozyme II, exemplified by the crystal structure of the topiramate sulfamide analogue.
    Winum JY; Temperini C; El Cheikh K; Innocenti A; Vullo D; Ciattini S; Montero JL; Scozzafava A; Supuran CT
    J Med Chem; 2006 Nov; 49(24):7024-31. PubMed ID: 17125255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbonic anhydrase inhibitors: X-ray crystal structure of a benzenesulfonamide strong CA II and CA IX inhibitor bearing a pentafluorophenylaminothioureido tail in complex with isozyme II.
    Di Fiore A; De Simone G; Menchise V; Pedone C; Casini A; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 Apr; 15(7):1937-42. PubMed ID: 15780637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and docking studies of new 1,3,4-thiadiazole-2-thione derivatives with carbonic anhydrase inhibitory activity.
    Abdel-Hamid MK; Abdel-Hafez AA; El-Koussi NA; Mahfouz NM; Innocenti A; Supuran CT
    Bioorg Med Chem; 2007 Nov; 15(22):6975-84. PubMed ID: 17822907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozymes I and II and tumor-associated isozymes IX and XII with S-substituted 4-chloro-2-mercapto-5-methyl-benzenesulfonamides.
    Saczewski F; Innocenti A; Sławiński J; Kornicka A; Brzozowski Z; Pomarnacka E; Scozzafava A; Temperini C; Supuran CT
    Bioorg Med Chem; 2008 Apr; 16(7):3933-40. PubMed ID: 18242998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbonic anhydrase inhibitors. Comparison of chlorthalidone and indapamide X-ray crystal structures in adducts with isozyme II: when three water molecules and the keto-enol tautomerism make the difference.
    Temperini C; Cecchi A; Scozzafava A; Supuran CT
    J Med Chem; 2009 Jan; 52(2):322-8. PubMed ID: 19115843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbonic anhydrase inhibitors. Sulfonamide diuretics revisited--old leads for new applications?
    Temperini C; Cecchi A; Scozzafava A; Supuran CT
    Org Biomol Chem; 2008 Jul; 6(14):2499-506. PubMed ID: 18600270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbonic anhydrase inhibitors. Interaction of the antiepileptic drug sulthiame with twelve mammalian isoforms: kinetic and X-ray crystallographic studies.
    Temperini C; Innocenti A; Mastrolorenzo A; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4866-72. PubMed ID: 17588751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of potent carbonic anhydrase inhibitors incorporating both sulfonamide and sulfamide groups.
    D'Ambrosio K; Smaine FZ; Carta F; De Simone G; Winum JY; Supuran CT
    J Med Chem; 2012 Aug; 55(15):6776-83. PubMed ID: 22775345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of the complex between human carbonic anhydrase II and the aromatic inhibitor 1,2,4-triazole.
    Mangani S; Liljas A
    J Mol Biol; 1993 Jul; 232(1):9-14. PubMed ID: 8331673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.